
TUCCATINN 150 MG
Tucatinib is an oral targeted tyrosine kinase inhibitor used for specific oncology treatment requirements under medical supervision.
Explore our comprehensive range of oncology and anti-cancer medicines. Browse complete product specifications, composition, strength, packaging, manufacturer and other available product information.
Browse our available product range and explore individual medicine specifications. Each product includes the available details such as strength, composition, brand, dosage form, packaging, manufacturer, treatment information and other relevant specifications.
Total Available Products
36 Anti-Cancer Products

Tucatinib is an oral targeted tyrosine kinase inhibitor used for specific oncology treatment requirements under medical supervision.

Acalabrutinib targeted anticancer medication prescribed for specific blood cancer treatment requirements.

Acalabrutinib based targeted anticancer medicine for prescribed oncology requirements.

Tucatinib based targeted therapy product supplied for prescribed oncology requirements.

Capecitabine based oral chemotherapy medicine used for prescribed oncology treatment requirements.

Lenvatinib based targeted therapy medicine for prescribed cancer treatment requirements.





























